Ondansetron and simvastatin added to treatment as usual in patients with schizophrenia: study protocol for a randomized controlled trial.

Trials

Volumn 14, Issue , 2013, Pages

  Chaudhry, Imran B ^a   Husain, Nusrat ^b   Husain, Mohammad O ^b   Hallak, Jamie ^b   Drake, Richard ^b   Kazmi, Ajmal ^b   Rahman, Raza ur ^b   Hamirani, Mohammad M ^b   Kiran, Tayyaba ^b   Mehmood, Nasir ^b   Stirling, John ^b   Dunn, Graham ^b   Deakin, Bill ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEUROLEPTIC AGENT; ONDANSETRON; SEROTONIN ANTAGONIST; SIMVASTATIN;

BRAZIL; CHECKLIST; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECTS; HUMAN; METHODOLOGY; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PAKISTAN; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; TIME; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; ANTIPSYCHOTIC AGENTS; BRAZIL; CHECKLIST; CLINICAL PROTOCOLS; COGNITION; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NEUROPSYCHOLOGICAL TESTS; ONDANSETRON; PAKISTAN; PSYCHIATRIC STATUS RATING SCALES; RESEARCH DESIGN; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEROTONIN ANTAGONISTS; SIMVASTATIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84891695296     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-101     Document Type: Article

References (0)